Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
lenvatinib
×
Gynecologic
×
Clear all
Filters
3
NCT03797326
2025-11-17
LEAP-005
Merck Sharp & Dohme LLC
Phase 2
Completed
611 enrolled
27 charts
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled
NCT03517449
2025-06-15
MK-3475-775
Eisai Inc.
Phase 3
Completed
827 enrolled
18 charts
1 FDA